ALDH1A2 and multiminicore myopathy: Furthermore, they demonstrated that the impaired acetyl-histone H3K27 binding to the promoter region of RALDH2 may account for the reduced expression of RALDH2 in ECFCs from patients with MMD, as demonstrated by chromatin immunoprecipitation assay.62